Genoimmune Therapeutics

About:

Genoimmune Therapeutics is a high-tech biotechnology enterprise dedicated to the treatment of tumor immune cells.

Website: http://genoimmune.genomics.cn/

Top Investors: Forebright Capital, GF Xinde Investment Management

Description:

Genoimmune Therapeutics is a holding subsidiary of Shenzhen Huada Gene Technology Co., Ltd. It is a high-tech biotechnology enterprise dedicated to the treatment of tumor immune cells. Through the use of advanced life digital technology, the human immune system can be fully stimulated against the tumor, and new advanced prevention and treatment programs targeting tumor-specific antigens can be developed to benefit patients. Since 2011, he has focused on the development of tumor genomes, bioinformatics and tumor immunity.

Total Funding Amount:

120M CNY

Headquarters Location:

Wuhan, Hubei, China

Founded Date:

2017-01-01

Contact Email:

genoimmune(AT)genomics.cn

Founders:

Bo Li

Number of Employees:

11-50

Last Funding Date:

2019-03-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai